EHA 2025 Congress

June 12-15, 2025
Milan, Italy

BIO International Convention 2025

July 2nd, 2025: MaaT Pharma Announces Exclusive Commercialization Partnership With Clinigen for Xervyteg® in acute Graft-versus Host Disease in Europe